Evaluation of papillary muscle function using cardiovascular magnetic resonance imaging in mitral valve prolapse

Yuchi Han1, Dana C Peters, Kraig V Kissinger

  • 1Department of Medicine (Cardiovascular Division), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. yhan@bidmc.harvard.edu

Insights

Papillary muscle (PM) dysfunction in mitral valve prolapse (MVP) increases PM systolic velocity and excursion. However, these functional changes did not correlate with the presence of PM fibrosis in MVP patients.

Area of Science:

  • Cardiovascular Imaging
  • Cardiac Electrophysiology
  • Valvular Heart Disease

Background:

  • Abnormal papillary muscle (PM) motion in mitral valve prolapse (MVP) can impact myocardial electrophysiologic stability.
  • Cardiovascular magnetic resonance (CMR) can quantify PM mechanics and visualize fibrosis.

Purpose of the Study:

  • To prospectively assess papillary muscle (PM) excursion and velocity in patients with mitral valve prolapse (MVP) using cardiovascular magnetic resonance (CMR).
  • To investigate the relationship between PM mechanical function and the presence of myocardial fibrosis in MVP.

Main Methods:

  • Prospective study of 16 MVP patients and 9 healthy controls.
  • Phase-contrast and cine CMR were used to measure PM tip velocity and excursion during systole.
  • Late gadolinium enhancement (LGE) CMR was performed in 13 MVP patients to assess for PM fibrosis.

Main Results:

  • Patients with MVP exhibited significantly increased peak PM systolic velocity (12 ± 5 cm/s vs 5 ± 2 cm/s, p < 0.001) and maximum PM excursion (15 ± 5 mm vs 2 ± 3 mm, p < 0.001) compared to controls.
  • Definite PM LGE (fibrosis) was identified in 6 of 13 MVP patients (46%).
  • PM fibrosis did not correlate with increased PM systolic velocity or excursion.

Conclusions:

  • Functional CMR imaging reveals significantly increased PM systolic velocity and excursion in MVP patients.
  • The observed functional abnormalities in PM motion in MVP are not associated with detectable PM fibrosis.
  • CMR-derived PM mechanics may offer insights into MVP pathophysiology, independent of fibrotic substrate.

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...